by Amanda Brahlek | Oct 24, 2025 | About
This is the website accessibility statement in line with Public Sector Body (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018. This website is run by the Deanery of Biomedical Sciences based at the University of Edinburgh. We want as many...
by Amanda Brahlek | Oct 24, 2025 | Clinical Pharmacology
Drugs for cytomegalovirus (CMV) infection The anti-human CMV drugs used currently target CMV replication via two distinct mechanisms. pUL54 inhibitors Ganciclovir (GCV; Cytovene) is a nucleoside analogue. It must be phosphorylated (to the nucleotide) by the viral...
by Amanda Brahlek | Oct 24, 2025 | Drugs
In patients with moderate to severe depression routine antidepressant therapy is effective (as highlighted by Cipriani et al. (2018) following meta-analysis of results from clinical trials of 21 different antidepressants)- and is recommended to be combined with...
by Amanda Brahlek | Aug 15, 2025 | Clinical Pharmacology
Pharmacokinetics can be simply described as the study of ‘what the body does to the drug’ and includes: • the rate and extent to which drugs are absorbed into the body and distributed to the body tissues• the rate and pathways by which drugs are...
by Amanda Brahlek | Feb 21, 2025 | Drugs
The respiratory system includes the lungs, airways, blood vessels and musculature that facilitate breathing and gas exchange. There are a range of conditions that compromise respiratory function, including inflammation (allergies, asthma), infections (pneumonia,...
